as on September 15, 2025 at 11:36 pm IST
Day's Low
Day's High
2.22%
Downside
2.36%
Upside
52 Week's Low
52 Week's High
50.05%
Downside
36.70%
Upside
Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.5B
EPS (TTM)
-3.7181
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-321.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
24090100.00%
Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.5B | 20.19% | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Akero Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Akero Therapeutics Inc investment value today
Current value as on today
₹1,61,240
Returns
₹61,240
(+61.24%)
Returns from Akero Therapeutics Inc Stock
₹56,255 (+56.25%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $77.3
Get share price movements and forecasts by analysts on Akero Therapeutics Inc.
What analysts predicted
44.73%UPSIDE
Target Price
$77.3
Current Price
$42.72
Analyzed by
16 Analysts
Target
$77.30
Akero Therapeutics Inc target price $77.3, a slight upside of 44.73% compared to current price of $42.72. According to 16 analysts rating.
Search interest for Akero Therapeutics Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 16.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 59.7%
Price Dip
In the last 1 month, AKRO stock has moved down by -12.0%
Organisation | Akero Therapeutics Inc |
Headquarters | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Andrew Cheng M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Andrew Cheng M.D., Ph.D. | President, CEO & Director |
Dr. Jonathan M. Young J.D., Ph.D. | Co-Founder, Executive VP, COO & Secretary |
Mr. Scott A. Gangloff | Chief Technical Officer |
Mr. Thomas Ross | Senior VP & Head of Legal |
Mr. William R. White J.D. | Executive VP, CFO, Treasurer & Head of Corporate Development |
Ms. Catriona Yale | Executive VP & Chief Development Officer |
Dr. Timothy Rolph Ph.D. | Co-Founder & Chief Scientific Officer |
Mr. John J. Schembri | Senior VP & Head of Finance |
Mr. Patrick Lamy | Senior Vice President of Commercial Strategy |
Akero Therapeutics Inc share price today is $42.72 as on . Akero Therapeutics Inc share today touched a day high of $43.73 and a low of $41.77.
Akero Therapeutics Inc share touched a 52 week high of $58.4 on and a 52 week low of $21.34 on . Akero Therapeutics Inc stock price today i.e. is trending at $42.72,which is 26.85% down from its 52 week high and 100.19% up from its 52 week low.
Akero Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Akero Therapeutics Inc share’s latest price of $42.72 as on September 15, 2025 at 11:36 pm IST, you will get 0.2341 shares of Akero Therapeutics Inc. Learn more about
fractional shares .
Akero Therapeutics Inc stock has given 20.19% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?